MARSHALL WACE, LLP

Position in FLNA — Filana Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in FLNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,401,197

-$787,109 QoQ

Shares Held

2,012,543

-4.9% QoQ

Ownership

4.17%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,756,303,735 across 280 Biotechnology names. FLNA ranks #125 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,099,318	$363,731,344
2	VRTX	Vertex Pharmaceuticals Inc / Ma	317,058	$141,579,078
3	INCY	Incyte Corp	1,253,138	$117,945,347
4	RPRX	Royalty Pharma plc	2,120,692	$101,729,594
5	RCUS	Arcus Biosciences, Inc.	3,761,437	$81,247,039
6	PTGX	Protagonist Therapeutics, Inc	628,075	$66,199,104
7	ROIV	Roivant Sciences Ltd.	2,246,943	$62,240,320
8	COGT	Cogent Biosciences, Inc.	1,600,168	$61,590,466

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,401,197	2,012,543	-4.9%	Shares	Other	2026-05-15
2025-12-31	$4,188,306	2,115,307	+2.6%	Shares	Other	2026-02-13
2025-09-30	$5,998,341	2,061,286	+2774.3%	Shares	Other	2025-11-13
2025-06-30	$129,802	71,714	+240.0%	Shares	Other	2025-08-13
2024-12-31	$49,779	21,093	-13.4%	Shares	Other	2025-02-13
2023-06-30	$597,012	24,348	-84.5%	Shares	Other	2023-08-14
2022-09-30	$6,579,331	157,325	-19.7%	Shares	Other	2022-11-14
2021-03-31	$8,807,592	195,942	-52.0%	Shares	Sole	2021-05-17
2020-12-31	$2,781,236	407,806	+1945.2%	Shares	Sole	2021-02-16
2020-09-30	$229,509	19,940	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.